Juntendo University, Tokyo, established in 1838.

  1. Home
  2. Juntendo University has become a sister institute of UTMDA
  3. Collaborative Achievement

Juntendo University has become a sister institute of UTMDA

 Top   Research   Education   Symposium & Seminor   Achievement
 Japanese     Index

Collaborative Achievement

Publications

  1. Lang FM, Hossain A, Gumin J, Momin EN, Shimizu Y, Ledbetter D, Shahar T, Yamashita S, Parker Kerrigan B, Fueyo J, Sawaya R, Lang FF. Mesenchymal stem cells as natural biofactories for exosomes carrying miR-124a in the treatment of gliomas. Neuro Oncol. 2018 Feb 19;20(3):380-390.
  2. Tabe Y, Saitoh K, Yang H, Sekihara K, Yamatani K, Ruvolo V, Taka H, Kaga N, Kikkawa M, Arai H, Miida T, Andreeff M, Spagnuolo PA, Konopleva M.Inhibition of FAO in AML co-cultured with BM adipocytes: mechanisms of survival and chemosensitization to cytarabine. Sci Rep. 2018 Nov 15;8(1):16837. doi: 10.1038/s41598-018-35198-6.
  3. Molina JR, Sun Y, Protopopova M, Gera S, Bandi M, Bristow C, McAfoos T, Morlacchi P, Ackroyd J, Agip AA, Al-Atrash G, Asara J, Bardenhagen J, Carrillo CC, Carroll C, Chang E, Ciurea S, Cross JB, Czako B, Deem A, Daver N, de Groot JF, Dong JW, Feng N, Gao G, Gay J, Do MG, Greer J, Giuliani V, Han J, Han L, Henry VK, Hirst J, Huang S, Jiang Y, Kang Z, Khor T, Konoplev S, Lin YH, Liu G, Lodi A, Lofton T, Ma H, Mahendra M, Matre P, Mullinax R, Peoples M, Petrocchi A, Rodriguez-Canale J, Serreli R, Shi T, Smith M, Tabe Y, Theroff J, Tiziani S, Xu Q, Zhang Q, Muller F, DePinho RA, Toniatti C, Draetta GF, Heffernan TP, Konopleva M, Jones P, Di Francesco ME, Marszalek JR. An inhibitor of oxidative phosphorylation exploits cancer vulnerability. Nat Med. 2018 Jul;24(7):1036-1046.
  4. Zhang Q, Shi C, Han L, Jain N, Roberts KG, Ma H, Cai T, Cavazos A, Tabe Y, Jacamo RO, Mu H, Zhao Y, Wang J, Wu SC, Cao F, Zeng Z, Zhou J, Mi Y, Jabbour EJ, Levine R, Tasian SK, Mullighan CG, Weinstock DM, Fruman DA, Konopleva M. Inhibition of mTORC1/C2 signaling improves anti-leukemia efficacy of JAK/STAT blockade inCRLF2 rearranged and/or JAK driven Philadelphia chromosome-like acute B-cell lymphoblastic leukemia. Oncotarget. 2018 Jan 17;9(8):8027-8041.
  5. Tabe Y, Konopleva M. Leukemia Stem Cells Microenvironment. Adv Exp Med Biol. 2017;1041:19-32.
  6. Tabe Y, Tafuri A, Sekihara K, Yang H, Konopleva M. Inhibition of mTOR kinase as a therapeutic target for acute myeloid leukemia. Expert Opin Ther Targets. 2017 Jul;21(7):705-714.
  7. Sekihara K, Saitoh K, Han L, Ciurea S, Yamamoto S, Kikkawa M, Kazuno S, Taka H, Kaga N, Arai H, Miida T, Andreeff M, Konopleva M, Tabe Y. Targeting mantle cell lymphoma metabolism and survival through simultaneous blockade of mTOR and nuclear transporter exportin-1. Oncotarget. 2017 May 23;8(21):34552-34564.
  8. Parker Kerrigan BC, Shimizu Y, Andreeff M, Lang FF. Mesenchymal stromal cells for the delivery of oncolytic viruses in gliomas. Cytotherapy. 2017 Apr;19(4):445-457.
  9. Tabe Y, Yamamoto S, Saitoh K, Sekihara K, Monma N, Ikeo K, Mogushi K, Shikami M, Ruvolo VR, Ishizawa J, Hail N, Kazuno S, Igarashi M, Matsushita H, Yamanaka Y, Arai H, Nagaoka I, Miida T, Hayashizaki Y, Konopleva M, Andreeff M. Survival of acute monocytic leukemia cells is driven by fatty acid oxidation-mediated activation of AMPK in bone marrow adipocytes. Cancer Res. 2017 Mar 15;77(6):1453-1464.
  10. Sekihara K, Saitoh K, Han L, Ciurea S, Yamamoto S, Kikkawa M, Kazuno S, Taka H, Kaga N, Arai H, Miida T, Andreeff M, Konopleva M,Tabe Y. Targeting mantle cell lymphoma exportin-1 Oncotarget. 2017 May 23;8(21):34552-34564
  11. Tabe Y, Tafuri A, Sekihara K, Yang H, Konopleva M. Inhibition of mTOR kinase as a therapeutic target for acute myeloid leukemia. Expert Opin Ther Targets. 2017 Jul;21(7):705-714
  12. Ishizawa J, Kojima K, Chachad D, Ruvolo P, Ruvolo V, Jacamo RO, Borthakur G, Mu H, Zeng Z, Tabe Y, Allen JE, Wang Z, Ma W, Lee HC, Orlowski R, Sarbassov dos D, Lorenzi PL, Huang X, Neelapu SS, McDonnell T, Miranda RN, Wang M, Kantarjian H, Konopleva M, Davis RE, Andreeff M.ATF4 induction through an atypical integrated stress response to ONC201 triggers p53-independent apoptosis in hematological malignancies. Sci Signal. 2016 Feb 16;9(415)
  13. Tabe Y, Hatanaka Y, Nakashiro M, Sekihara K, Yamamoto S, Matsushita H, Kazuno S, Fujimura T, Ikegami T, Nakanaga K, Matsumoto H, Ueno T, Aoki J, Yokomizo T, Konopleva M, Andreeff M, Miida T, Iwabuchi K, Sasai K. Integrative genomic and proteomic analyses identifies glycerol-3-phosphate acyltransferase as a target of low-dose ionizing EBV infected-B cells. Int J Radiat Biol. 2016 Jan;92(1):24-34.
  14. Tabe Y, Konopleva M. Role of Microenvironment in Resistance to Therapy in AML. Curr Hematol Malig Rep. 2015;10(2):96-103.
  15. Tabe Y, Kojima K, Matsushita H, Davis ER, Ishizawa J, Kazuno S, Kauffman M, Shacham S, Fujimura T, Ueno T, Miida T, Andreeff M. Ribosomal biogenesis and translational flux inhibition by the selective inhibitor of nuclear export (SINE) XPO1 antagonist KPT-185. PLoS One. 2015;10(9):e0137210.
  16. Ishizawa J, Kojima K, Hail N Jr, Tabe Y, Andreeff M. Expression, function, and targeting of the nuclear exporter chromosome region maintenance 1 (CRM1) protein. Pharmacol Ther. 2015;153:25-35.
  17. Harada M, Benito J, Yamamoto S, Kaur S, Arslan D, Ramirez S, Jacamo R, Platanias L, Matsushita H, Fujimura T, Kazuno S, Kojima K, Tabe Y, Konopleva M. The novel combination of dual mTOR inhibitor AZD2014 and pan-PIM inhibitor AZD1208 inhibits growth in acute myeloid leukemia via HSF pathway suppression. Oncotarget. 2015;6(35):37930-47.
  18. Tabe Y, Konopleva M.Advances in understanding the leukaemia microenvironment. Br J Haematol. 2014;164(6):767-78.
  19. Yoshimura M, Ishizawa J, Ruvolo V, Dilip A, Quintas-Cardama A, McDonnell TJ, Neelapu SS, Kwak LW, Shacham S, Kauffman M, Tabe Y, Yokoo M, Kimura S, Andreeff M, Kojima K. Induction of p53-mediated transcription and apoptosis by Exportin-1 (XPO1) inhibition in mantle cell lymphoma. Cancer Sci. 105:795-801.2014
  20. Tabe Y, Jin L, Konopleva M, Shikami M, Kimura S, Andreeff M, Raffeld M, Miida T. Class IA PI3K inhibition inhibits cell growth and proliferation in mantle cell lymphoma. Acta Haematologica. 131:59-69. 2014

Conference Presentations

  1. Tian Y, Denda-Nagai K, Ishii-Schrade K, Matsuzaki K, Hafley M, Bresalier R, Irimura T. Mucin 21 confers resistance to apoptosis in an O-glycosylation dependent manner. GAP 2019 Conference, Houston, 2019.
  2. Miyatsu T, Okamoto A. Factors enabling breast cancer patients to continue working during post-operative radiotherapy. GAP 2019 Conference, Houston, 2019.
  3. Kurihara A, Tabe Y Conflicted feeling of the cancer patient with mother-daughter relationship problem. GAP 2019 Conference, Houston, 2019.
  4. Kimura K, Tabe Y, Ai T, Takehara, Uchihashi K, Ohsaka A. A novel automated image analysis using deep convolutional neural networks in the diagnosis of myelodysplastic syndromes. GAP 2019 Conference, Houston, 2019.
  5. Yamatani K, Tabe Y, Saito K, Yang H, Zhang W, Kinjo S, Ikeo K, Kaczkowski B, Miida T, Konopleva M, Hayashizaki Y, Andreeff M. CAGE transcriptome identified Bcl-2 as a novel molecular target of FLT3-ITD AML with acquired TKD mutation. GAP 2019 Conference, Houston, 2019.
  6. Tabe Y, Yang H, Saito K, Jacamo R, Ma H, Ruvolo V, Imoto J, Ikeo K, Yamatani K, Miida T, Hayashizaki Y, Andreeff M, Marszalek J,  Konopleva M, Tunneling NanoTubes formation as a mechanism of microenvironment-induced resistance to OxPhos inhibition in AML. GAP 2019 Conference, Houston, 2019.
  7. Tabe Y. Mitochondrial transfer confers microenvironment-mediated resistance to oxphos inhibition in AML. GAP 2019 Conference, Houston, 2019.
  8. Shimizu Y. Kondo A, Adachi S, Arai H. The Role of KIAA1549-BRAF Fusion Gene in Pediatric Brain Tumor. GAP 2019 Conference, Houston, 2019.
  9. Fujita N, Kondo A, Arai H. Molecular subgrouping of posterior fossa ependymoma by CRIP1 gene methylation status. GAP 2019 Conference, Houston, 2019.
  10. Nagaya N. The expression of PSMA in CTCs as a predictive marker for poor treatment response in CRPC. GAP 2018 Conference, Stockholm, 2018.
  11. Tabe Y. Novel Oxidative phosphorylation inhibitor IACS-010759 inhibits p38MAPK-NFkB signaling pathways. GAP 2018 Conference, Stockholm, 2018.
  12. Uehara Y. Enterobacter species bacteremia in patients with malignancy: a pilot analysis. GAP 2018 Conference, Stockholm, 2018.
  13. Kurihara A. Grief caused by the death of female cancer patients：daughters perspectives. GAP 2018 Conference, Stockholm, 2018.
  14. Fujimura Y. Intervention through multi-professional collaboration for older people with malnutrition by cancer. GAP 2018 Conference, Stockholm, 2018.
  15. Ohsaka A. Eprobe mediated RT-qPCR for the detection of leukemia-associated translocations. GAP 2018 Conference, Stockholm, 2018.
  16. Kimura K. Development and validation of a Deep Learning Algorithm for detection of abnormal morphology of WBC. GAP 2018 Conference, Stockholm, 2018.
  17. Tabe Y, Yamatani K, Yang H, Saito K, Murakami-Tonami Y, Suzuki K, Zhang W, Kinjo S, Ikeo K, Kaczkowski B, Hosoya M, Mogushi K, Yamaguchi S, Harada H, Miida T, Shah PN, Konopleva M, Hayashizaki Y, Andreeff M. Combined targeting of Bcl-2 and XPO1 overcomes acquired resistance to tyrosine kinase inhibitors in FLT3-ITD/TKD double mutant AML. 60th American Society of Hematology Annual Meeting, SanDiego, 2018
  18. Yang H, Tabe Y, Saitoh K, Jacamo R, Ma H, Ruvolo V, Imoto J, Ikeo K, Mogushi K, Hosoya M, Yamaguchi S, Yamatani K, Murakami-Tonami Y, Suzuki K, Miida T, Andreeff M, Marszalek JR, Konopleva M. Mitochondrial transfer confers microenvironment-mediated resistance to OxPhos inhibition in AML. 60th American Society of Hematology Annual Meeting, SanDiego, 2018
  19. Yamatani K, Tabe Y, Saitoh K, Yang H, Murakami-Tonami Y, Suzuki K, Zhang W, Kinjo S, Ikeo K, Kaczkowski B, Mogushi K, Hosoya M, Yamaguchi S, Harada H, Miida T, Shah PN, Konopleva M, Hayashizaki Y, Andreeff M. Upregulation of Bcl-2 confers resistance to FLT3 inhibition in FLT3-ITD AML with secondary acquired mutations. 60th American Society of Hematology Annual Meeting, SanDiego, 2018
  20. Araki M. Mutant Calreticulin activates the thrombopoietin receptor in myeloproliferative neoplasms. GAP 2017 Conference, Houston, 2017.
  21. Shimizu Y. Characterization of Patient Derived Bone-Marrow Human Mesenchymal Stem Cells as Virus Carriers for the Treatment of Glioblastoma. GAP 2017 Conference, Houston, 2017.
  22. Tabe Y. Bone marrow adipocytes facilitate fatty acid oxidation activating AMPK and a transcriptional network supporting survival of acute monocytic leukemia cells. GAP 2017 Conference, Houston, 2017.
  23. Kanayama M. Differentiation in LNCaP Prostate Cancer Cell with Concurrent Up-regulation of Interferon Regulatory Factor 1. GAP 2017 Conference, Houston, USA, 2017.
  24. Uehara Y. Molecular types of newly-isolated methicillin-resistant Staphylococcus aureus in a month, 2015, in a Japanese university hospital. GAP 2017 Conference, Houston, 2017.
  25. Sekihara K, Saitoh K, Yang H, Miida T, Andreeff M, Tabe Y. Combinatorial Inhibition of mTOR and Exportin-1 (XPO1) Represses Cell Survival Via Metabolic Modulation of Pro-survival Pathways in Mantle Cell Lymphomas. European Society for Medical Oncology (ESMO) 2017 congress. Madrid. 2017.
  26. Yang H, Tabe Y, Sekihara K, Saitoh K, Ma H, Ruvolo V, Imoto J, Ikeo K, Mogushi K, Hosoya M, Hayashizaki Y, Yamanaka Y, Miida T, Andreeff M, Marszalek J, Konopleva M. Novel Oxidative phosphorylation inhibitor IACS-010759 induces AMPK-dependent apoptosis of AML cells. 59th American Society of Hematology Annual Meeting, Atlanta, 2017
  27. Tabe Y, Sekihara K, Yang H, Saito K, Ruvolo V, Taka H, Kaga N, Miida T, Andreeff M, Spagnuolo PA, Konopleva M. Inhibition of FAO in AML co-cultured with BM adipocytes: mechanisms of survival and chemosensitization to cytarabine. 59th American Society of Hematology Annual Meeting, Atlanta, 2017
  28. Yamatani K, Tabe Y, Sekihara K, Yang H, Saito K, Ruvolo V, Zhang W, Kinjo S, Ikeo K, Mogushi K, Hosoya M, Hayashizaki Y, Yamanaka Y, Harada H, Miida T, Konopleva M, Andreeff M. XPO1 inhibition targets transcriptional vulnerability of FLT3-ITD+D835 double mutant AML through p53 accumulation and inhibition of oncogenic transcription factors: lesson learned from CAGE sequencing of primary AML cells. 59th American Society of Hematology Annual Meeting, Atlanta, 2017
  29. Kondo A. The impact of molecular analysis for pediatric brain tumors in clinical field. GAP 2016 Conference, São Paulo, Brazil, 2016.
  30. Kondo A. Overexpression of TEAD4 in AT/RT; New insight to the pathophysiology of an aggressive brain tumor. GAP 2016 Conference, São Paulo, Brazil, 2016.
  31. Imai M. Identification of candidate genes for granulosa cell tumor progression. GAP 2016 Conference, São Paulo, Brazil, 2016.
  32. Sekihara K, Saitoh K, Miida T, Andreeff M, Konopleva M, Tabe Y. The simultaneous blockade of mTOR and nuclear transporter exportin-1 induces synergistic antitumor effect through pro-survival metabolism in mantle cell lymphoma. Society of Hematologic Oncology Fourth Annual Meeting. Houston, 2016
  33. Tabe Y, Sekihara K, Saitoh K, Ruvolo V, Miida T, Andreeff M, Spagnuolo PA, Konopleva M. Novel fatty acid oxidation inhibitor avocatinB induces AMPK-dependent apoptosis of AML cells co-cultured with BM-adipocytes. 58th American Society of Hematology Annual Meeting and Exposition. San Diego, 2016
  34. Tabe Y, Sekihara K, Saitoh K, Monma K, Ikeo K, Kaczkowski B, Zhang W, Yamanaka Y, Miida T, Shah NP, Harada H, Hayashizaki Y, Konopleva M, Andreeff M. Cap analysis of gene expression (CAGE) sequencing reveals alterations of the transcriptional signatures of FLT3-ITD with secondary D835 TKD mutations in acute myeloid leukemia. 58th American Society of Hematology Annual Meeting and Exposition. San Diego, 2016
  35. Tabe Y, Mogushi K, Kazuno S, Fujimura T, Samudio I, Yamanaka Y, Miida T, Konopleva M, Hayashizaki Y, Andreeff M. Bone marrow adipocytes induced activation of fatty acid oxidation contributes to survival of acute monocytic leukemia cells. GAP 2015 Conference, Houston, 2015.
  36. Ishizawa J, Jacamo RO, Kojima K, Chachad D, Ruvolo V, Ruvolo P, Wang Z, Tabe Y, Konopleva M, Devine W, Lindquist S, Porco JA, Whitesell L, Andreeff M. Inactivating Heat Shock Factor 1 (HSF1) in Acute Myeloid Leukemia by Pharmacological Inhibition of eIF4a: A Promising Therapeutic Approach. 57th American Society of Hematology Annual Meeting, Orlando, 2015.
  37. Tabe Y, Konopleva M, Momna N, Ikeo K, Mogushi K, Yamanaka Y, Matsushita H, Miida T, Hayashizaki Y, Andreeff M. Cap analysis of gene expression (CAGE) sequencing reveals alterations of the transcript signatures in acute monocytic leukemia cells by fatty acid oxidation inhibition. 57th American Society of Hematology Annual Meeting, Orlando, 2015.
  38. Tabe Y, Yamamoto S, Kikkawa M, Taka H, Kaga N, Mogushi K, Matsushita H, Miida T, Andreeff M, Spagnuolo PA, Konopleva M. Novel FAO inhibitor avocatin B induces apoptosis of acute monocytic leukemia cells in adipocyte co-culture system via ER stress and ATF4 activation. 57th American Society of Hematology Annual Meeting, Orlando, 2015.
  39. Ishizawa J, Kojima K, Chachad D, Ruvolo P, Ruvolo V, Jacamo RO, Borthakur G, Mu H, Zeng Z, Tabe Y, Allen JE, Wang Z, Ma W, Lee HC, Orlowski R, Sarbassov DD, Neelapu SS, McDonnell T, Miranda1 RN, Wang M, Kantarjian H, Konopleva M, Eric Davis R, Andreeff M. ONC201 Induces p53-independent Apoptosis and Abrogates Stem Cell Function in Hematological Malignancies by Induction of ATF4 Through Integrated Stress Response. 57th American Society of Hematology Annual Meeting, Orlando, 2015.
  40. Tabe Y, Kojima K, Jin L, Iwanami H, Matsushita H, Kazuno S, Kauffman M, Shacham S, Fujimura T, Ueno T, Miida T, Andreeff M. Molecular mechanisms of inhibition of ribosomal biogenesis and translational flux by the Selective Inhibitor of Nuclear Export (SINE) XPO1/CRM1 antagonist KPT-185 in mantle cell lymphoma. GAP 2014 Conference, Seoul, 2014.
  41. Tabe Y, Harada M, Miyamae Y, Mogushi K, Kazuno S, Fujimura T, Matsushita H, Ueno T, Yokomizo T, Samudio I, Andreeff M, Konopleva M. Bone marrow adipocyte-derived free fatty acids induce gene signature linking transcription with metabolic changes that contribute to survival of acute monocytic leukemia cells. 56th American Society of Hematology Annual Meeting, San Francisco, 2014.
  42. Tabe Y, Harada M, Miyamae Y, Fujimura T, Kazuno S, Ueno T, Miida T, Andreeff M, Konopleva M. Metabolic re-programming in Notch-activated T-ALL by mTOR inhibitor AZD2014 combined with L-Asparaginase. 56th American Society of Hematology Annual Meeting, San Francisco, 2014.
  43. Tabe Y, Harada M, Miyamae Y, Kazuno S, Fujimura T, Ueno T, Miida T, Konopleva M, Andreeff M. Selective inhibitor of nuclear export selinexor (KPT-330) and BCL2 inhibitor ABT-199 enhance the anti-lymphoma effect of BTK inhibitor ibrutinib in mantle cell lymphoma. 56th American Society of Hematology Annual Meeting, San Francisco, 2014.
  44. Tabe Y, Harada M, Miyamae Y, Matsushita H, Kojima K, Fujimura T, Kazuno S, Ueno T, Miida T, Konopleva M, Andreeff M. The mTOR kinase inhibitor AZD-2014 effectively reverses XPO1/CRM1 antagonist KPT-185–induced glycolysis / gluconeogenesis, enhancing antitumor effects in mantle cell lymphoma. 56th American Society of Hematology Annual Meeting, San Francisco, 2014.
  45. Tabe Y, Hatanaka Y, Ruvolo P, Miida T, Kornblau S, Andreeff M, Konopleva M. Pro-survival effects of TGF-β1 are associated with molecular signaling changes of ERK, FLI-1, and CD44 in AML cells. 56th American Society of Hematology Annual Meeting, San Francisco, 2014.

Grants

  1. Tabe Y (JU): Target the leukemia cell metabolism by OxPhos inhibition. Grant-in-Aid for Scientific Research (C), Japan, 2018.
    (JU / MDA collaboration)
  2. Konopleva M (MDA), Tabe Y (JU): Targeting AML by OxPhos inhibition in the hypoxic microenvironment. Sister Institution Network Fund, 2014.
    (JU / MDA collaboration)
  3. Tabe Y (JU): Alterations of the transcript signatures by OxPhos inhibition in acute myeloid leukemia cells; in vivo analysis. Basis for Supporting Innovative Drug Discovery and Life Science Research, Japan, 2017.
    (JU / MDA / RIKEN collaboration)
  4. Harada H (JU): Transcriptome analysis of recurrently deregulated genes across AML patients with secondary mutations acquired during treatment with FLT3 inhibitor. Platform for drug discovery, informatics and structural life science grant for CAGE analysis, 2016.
    (JU / MDA / RIKEN collaboration)
  5. Sekihara K (JU): Alterations of the transcript signatures by OxPhos metabolism inhibition in acute myeloid leukemia cells; a concept for the elimination of residual acute myeloid leukemia in the adult bone marrow microenvironment. Platform for drug discovery, informatics and structural life science grant for CAGE analysis, Japan, 2016.
    (JU / MDA / RIKEN collaboration)
  6. Ueno N (MDA), Saito T (JU): Targeting the variant form of CD44 in triple-negative and inflammatory breast cancer. Sister Institution Network Fund, 2014.
    (JU / MDA collaboration)
  7. Tabe Y (JU): Bone marrow adipocytes induced alteration of energy metabolism and transcription network contributes survival of acute monocytic leukemia cells. Grant-in-Aid for Scientific Research (C), Japan, 2014.
    (JU / MDA / RIKEN collaboration)
  8. Harada H (JU): Cap analysis of gene expression (CAGE) sequencing reveals alterations of the transcript signatures in tyrosine kinase inhibitor resistant acute myeloid leukemia cells. Platform for drug discovery, informatics and structural life science grant for CAGE analysis, 2014.
    (JU / MDA / RIKEN collaboration)
  9. Tabe Y (JU): Cap analysis of gene expression (CAGE) sequencing reveals alterations of the transcript signatures in acute monocytic leukemia cells by fatty acid oxidation inhibition. Platform for drug discovery, informatics and structural life science grant for CAGE analysis, Japan, 2014.
    (JU / MDA / RIKEN collaboration)
  10. Irimura T (JU) : JSPS Core-to-Core program on International Core Research Center for NanoBio.
    http://park.itc.u-tokyo.ac.jp/c2cnanobio/english/index.html
  11. Irimura T (JU) : JSPS Core-to-Core program on International Core Research Center for Phototheranostics.
    http://www.f.u-tokyo.ac.jp/~c2c/outline.html
 Top   Research   Education   Symposium & Seminor   Achievement
 Japanese     Index
To Page Top